Deficiency in type 1 insulin-like growth factor receptor in mice protects against oxygen-induced lung injury

被引:31
作者
Ahamed, K
Epaud, R
Holzenberger, M
Bonora, M
Flejou, JF
Puard, J
Clement, A
Henrion-Caude, A [1 ]
机构
[1] Hop St Antoine, INSERM, U719, F-75012 Paris, France
[2] Hop St Antoine, INSERM, U515, F-75012 Paris, France
[3] Hop St Antoine, Dept Pathol, F-75012 Paris, France
来源
RESPIRATORY RESEARCH | 2005年 / 6卷 / 1期
关键词
D O I
10.1186/1465-9921-6-31
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Cellular responses to aging and oxidative stress are regulated by type 1 insulin-like growth factor receptor (IGF-1R). Oxidant injury, which is implicated in the pathophysiology of a number of respiratory diseases, acutely upregulates IGF-1R expression in the lung. This led us to suspect that reduction of IGF-1R levels in lung tissue could prevent deleterious effects of oxygen exposure. Methods: Since IGF-1R null mutant mice die at birth from respiratory failure, we generated compound heterozygous mice harboring a hypomorphic (Igf-1 r(neo)) and a knockout (Igf-1r(-)) receptor allele. These IGF-1R(neo/-) mice, strongly deficient in IGF-1R, were subjected to hyperoxia and analyzed for survival time, ventilatory control, pulmonary histopathology, morphometry, lung edema and vascular permeability. Results: Strikingly, after 72 h of exposure to 90% O-2, IGF-1R(neo/-) mice had a significantly better survival rate during recovery than IGF-1R(+/+) mice (77% versus 53%, P < 0.05). The pulmonary injury was consistently, and significantly, milder in IGF-1R(neo/-) mice which developed conspicuously less edema and vascular extravasation than controls. Also, hyperoxia-induced abnormal pattern of breathing which precipitated respiratory failure was elicited less frequently in the IGF-1R(neo/-) mice. Conclusion: Together, these data demonstrate that a decrease in IGF-1R signaling in mice protects against oxidant-induced lung injury.
引用
收藏
页数:11
相关论文
共 41 条
[1]  
ADACHI Y, 2004, NOVART FDN SYMP, V262, P190
[2]  
ADACHI Y, 2004, NOVART FDN SYMP, V262, P265
[3]  
Adachi Yasushi, 2004, Novartis Found Symp, V262, P177
[4]  
Adhikari N, 2004, COCHRANE DB SYST REV, V2004
[5]   Growth factors in idiopathic pulmonary fibrosis: relative roles [J].
Allen, JT ;
Spiteri, MA .
RESPIRATORY RESEARCH, 2001, 3 (01)
[6]  
ARIELI R, 1994, AVIAT SPACE ENVIR MD, V65, P1122
[7]   Oxygen toxicity in mouse lung: Pathways to cell death [J].
Barazzone, C ;
Horowitz, S ;
Donati, YR ;
Rodriguez, I ;
Piguet, PF .
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY, 1998, 19 (04) :573-581
[8]   Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury [J].
Barazzone, C ;
Belin, D ;
Piguet, PF ;
Vassalli, JD ;
Sappino, AP .
JOURNAL OF CLINICAL INVESTIGATION, 1996, 98 (12) :2666-2673
[9]   CONTROL OF BREATHING IN EXPERIMENTAL ANEMIA [J].
BARTLETT, D ;
TENNEY, SM .
RESPIRATION PHYSIOLOGY, 1970, 10 (03) :384-&
[10]   Insulin-like growth factor-1 (IGF-1) and IGF-1 receptor (IGF-1R) expression in human lung in RDS and BPD [J].
Chetty, A ;
Andersson, S ;
Lassus, P ;
Nielsen, HC .
PEDIATRIC PULMONOLOGY, 2004, 37 (02) :128-136